These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12218232)

  • 1. Trauma-localized fixed drug eruption: involvement of burn scars, insect bites and venipuncture sites.
    Mizukawa Y; Shiohara T
    Dermatology; 2002; 205(2):159-61. PubMed ID: 12218232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fixed drug eruption: state of the art.
    Ozkaya E
    J Dtsch Dermatol Ges; 2008 Mar; 6(3):181-8. PubMed ID: 18076661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful desensitization to fixed drug eruption: the presence of CD25+CD4+ T cells in the epidermis of fixed drug eruption lesions may be involved in the induction of desensitization.
    Teraki Y; Shiohara T
    Dermatology; 2004; 209(1):29-32. PubMed ID: 15237264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fixed drug eruption. A brief review.
    Korkij W; Soltani K
    Arch Dermatol; 1984 Apr; 120(4):520-4. PubMed ID: 6231004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postcoital fixed drug eruption in a man sensitive to trimethoprim-sulphamethoxazole.
    Gruber F; Stasić A; Lenković M; Brajac I
    Clin Exp Dermatol; 1997 May; 22(3):144-5. PubMed ID: 9425695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudoephedrine may cause "pigmenting" fixed drug eruption.
    Ozkaya E; Elinç-Aslan MS
    Dermatitis; 2011 May; 22(3):E7-9. PubMed ID: 21569741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fixed drug eruption: primary site involvement on maximal points of Head's zones.
    Ozkaya E
    Acta Derm Venereol; 2007; 87(6):517-20. PubMed ID: 17989890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generalized Bullous Fixed Drug Eruption due to Bromhexine.
    Vide J; Moreira C; Cunha AP; Baldaia H; Magina S; Azevedo F
    Dermatol Online J; 2016 Jul; 22(7):. PubMed ID: 27617726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fixed drug eruptions due to cotrimoxazole.
    Miah MA; Ahmed SS; Chowdhury SA; Begum F; Rahman SH
    Mymensingh Med J; 2008 Jul; 17(2 Suppl):S1-5. PubMed ID: 18946439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bullous fixed drug eruption masquerading as recurrent Stevens Johnson syndrome.
    Dharamsi FM; Michener MD; Dharamsi JW
    J Emerg Med; 2015 May; 48(5):551-4. PubMed ID: 25433836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible role of Fas/Fas ligand-mediated apoptosis in the pathogenesis of fixed drug eruption.
    Choi HJ; Ku JK; Kim MY; Kang H; Cho SH; Kim HO; Park YM
    Br J Dermatol; 2006 Mar; 154(3):419-25. PubMed ID: 16445769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fixed drug eruption from piroxicam.
    Cuerda Galindo E; Goday Buján JJ; García Silva JM; Martínez W; Verea Hernando M; Fonseca E
    J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):586-7. PubMed ID: 15324401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug related clinical pattern in fixed drug eruption.
    Ozkaya-Bayazit E; Bayazit H; Ozarmagan G
    Eur J Dermatol; 2000 Jun; 10(4):288-91. PubMed ID: 10846256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fixed drug eruption to clarithromycin: The importance of challenge tests in diagnosis].
    Huynh VA; Lungoci E; Villani A; Ben Said B; Hacard F; Nicolas JF; Bérard F
    Ann Dermatol Venereol; 2016 Dec; 143(12):852-855. PubMed ID: 27080820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonsteroidal anti-inflammatory drugs-induced generalized fixed drug eruption: two cases.
    Bilgili SG; Calka O; Karadag AS; Akdeniz N; Kosem M
    Hum Exp Toxicol; 2012 Feb; 31(2):197-200. PubMed ID: 21677025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fixed drug eruption to cetirizine with positive lesional patch tests to the three piperazine derivatives.
    Cravo M; Gonçalo M; Figueiredo A
    Int J Dermatol; 2007 Jul; 46(7):760-2. PubMed ID: 17614812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A three-year-analysis of fixed drug eruptions in hospital settings in France.
    Brahimi N; Routier E; Raison-Peyron N; Tronquoy AF; Pouget-Jasson C; Amarger S; Machet L; Amsler E; Claeys A; Sassolas B; Leroy D; Grange A; Dupuy A; Cordel N; Bonnetblanc JM; Milpied B; Doutre MS; Guinnepain MT; Barbaud A; Chosidow O; Roujeau JC; Lebrun-Vignes B; Descamps V
    Eur J Dermatol; 2010; 20(4):461-4. PubMed ID: 20507840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodeoxycholic acid induced generalized fixed drug eruption.
    Ozkol HU; Calka O; Dulger AC; Bulut G
    Cutan Ocul Toxicol; 2014 Sep; 33(3):256-8. PubMed ID: 24147950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fixed drug eruption from atezolizumab.
    Kearns D; Gardner JT; Kerstetter J; Furukawa B
    Dermatol Online J; 2022 Jan; 28(1):. PubMed ID: 35499418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple fixed drug eruption caused by iomeprol (Iomeron), a nonionic contrast medium.
    Watanabe H; Sueki H; Nakada T; Akiyama M; Iijima M
    Dermatology; 1999; 198(3):291-4. PubMed ID: 10393456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.